Pub Date : 2022-06-01eCollection Date: 2021-01-01DOI: 10.1080/19585969.2022.2042163
L Malandain, S Mosser, S Mouchabac, J-V Blanc, C Alexandre, F Thibaut
Introduction: Chemsex is defined by the use of psychoactive substances to facilitate or improve sexual relations. Our objectives were to assess the prevalence of the practice of 'chemsex' in a population of French university students and to identify socio-demographic and clinical factors associated with this practice.
Material and methods: We have used an anonymous online questionnaire comprising 15 questions on socio-demographic characteristics, chemsex use, sexual satisfaction, the type of substances used in this sexual context and their route of administration.
Results: A total of 680 people were included in our study. Among them, 22.5% reported chemsex behaviour in the past year. Using a multivariate analysis, factors associated with chemsex were dating application use (p = 0.049) and pornography use [viewing more than once per month (p = 0.002)]. Having a sexual partner involved in chemsex (p < 0.0001), celibacy (p = 0.007), sexual orientations other than heterosexual (p = 0.0013) and especially bisexuality (p = 0.0002) were also significantly associated with chemsex.
Conclusion: This is the first study reporting a high prevalence of chemsex in a university student population. Further larger studies should be conducted to confirm these results showing a high prevalence of this at-risk behaviour.
{"title":"Chemical sex (chemsex) in a population of French university students.","authors":"L Malandain, S Mosser, S Mouchabac, J-V Blanc, C Alexandre, F Thibaut","doi":"10.1080/19585969.2022.2042163","DOIUrl":"https://doi.org/10.1080/19585969.2022.2042163","url":null,"abstract":"<p><strong>Introduction: </strong>Chemsex is defined by the use of psychoactive substances to facilitate or improve sexual relations. Our objectives were to assess the prevalence of the practice of 'chemsex' in a population of French university students and to identify socio-demographic and clinical factors associated with this practice.</p><p><strong>Material and methods: </strong>We have used an anonymous online questionnaire comprising 15 questions on socio-demographic characteristics, chemsex use, sexual satisfaction, the type of substances used in this sexual context and their route of administration.</p><p><strong>Results: </strong>A total of 680 people were included in our study. Among them, 22.5% reported chemsex behaviour in the past year. Using a multivariate analysis, factors associated with chemsex were dating application use (<i>p</i> = 0.049) and pornography use [viewing more than once per month (<i>p</i> = 0.002)]. Having a sexual partner involved in chemsex (<i>p</i> < 0.0001), celibacy (<i>p</i> = 0.007), sexual orientations other than heterosexual (<i>p</i> = 0.0013) and especially bisexuality (<i>p</i> = 0.0002) were also significantly associated with chemsex.</p><p><strong>Conclusion: </strong>This is the first study reporting a high prevalence of chemsex in a university student population. Further larger studies should be conducted to confirm these results showing a high prevalence of this at-risk behaviour.</p>","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"23 1","pages":"39-43"},"PeriodicalIF":8.3,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01eCollection Date: 2021-01-01DOI: 10.1080/19585969.2022.2073566
Lakshmi N Yatham, Florence Thibaut
{"title":"Translational chasm and dialogues in clinical neuroscience.","authors":"Lakshmi N Yatham, Florence Thibaut","doi":"10.1080/19585969.2022.2073566","DOIUrl":"10.1080/19585969.2022.2073566","url":null,"abstract":"","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"23 1","pages":"1-2"},"PeriodicalIF":8.3,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01eCollection Date: 2021-01-01DOI: 10.1080/19585969.2022.2042166
Marc-Antoine Crocq
This article is a historical review of the medical and psychiatric diagnoses associated with transgender people across epochs. Ancient Greek and Roman writings already mention gender change. Before a diagnosis even existed, historical documents described the lives of numerous people whom we would consider transgender today. The development of medical classifications took off in the nineteenth century, driven by the blooming of natural sciences. In the nineteenth century, most authors conflated questions of sexual orientation and gender. For example, the psychiatrist Krafft-Ebing reported cases of transgender people but understood them as paranoia, or as the extreme degree of severity in a dimension of sexual inversion. In the early 1900s, doctors such as Magnus Hirschfeld first distinguished homosexual and transgender behaviour. The usual term for transgender people was transvestite, before Harry Benjamin generalised the term transsexual in the mid-20th century. The term transgender became common in the 1970s. This article details the evolution of diagnoses for transgender people from DSM-III and ICD-10 to DSM-5 and ICD-11.
{"title":"How gender dysphoria and incongruence became medical diagnoses - a historical review.","authors":"Marc-Antoine Crocq","doi":"10.1080/19585969.2022.2042166","DOIUrl":"https://doi.org/10.1080/19585969.2022.2042166","url":null,"abstract":"<p><p>This article is a historical review of the medical and psychiatric diagnoses associated with transgender people across epochs. Ancient Greek and Roman writings already mention gender change. Before a diagnosis even existed, historical documents described the lives of numerous people whom we would consider transgender today. The development of medical classifications took off in the nineteenth century, driven by the blooming of natural sciences. In the nineteenth century, most authors conflated questions of sexual orientation and gender. For example, the psychiatrist Krafft-Ebing reported cases of transgender people but understood them as paranoia, or as the extreme degree of severity in a dimension of sexual inversion. In the early 1900s, doctors such as Magnus Hirschfeld first distinguished homosexual and transgender behaviour. The usual term for transgender people was transvestite, before Harry Benjamin generalised the term transsexual in the mid-20th century. The term transgender became common in the 1970s. This article details the evolution of diagnoses for transgender people from DSM-III and ICD-10 to DSM-5 and ICD-11.</p>","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"23 1","pages":"44-51"},"PeriodicalIF":8.3,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: A severe form of pathological social withdrawal, 'hikikomori,' has been acknowledged in Japan, spreading worldwide, and becoming a global health issue. The pathophysiology of hikikomori has not been clarified, and its biological traits remain unexplored.
Methods: Drug-free patients with hikikomori (n = 42) and healthy controls (n = 41) were recruited. Psychological assessments for the severity of hikikomori and depression were conducted. Blood biochemical tests and plasma metabolome analysis were performed. Based on the integrated information, machine-learning models were created to discriminate cases of hikikomori from healthy controls, predict hikikomori severity, stratify the cases, and identify metabolic signatures that contribute to each model.
Results: Long-chain acylcarnitine levels were remarkably higher in patients with hikikomori; bilirubin, arginine, ornithine, and serum arginase were significantly different in male patients with hikikomori. The discriminative random forest model was highly performant, exhibiting an area under the ROC curve of 0.854 (confidential interval = 0.648-1.000). To predict hikikomori severity, a partial least squares PLS-regression model was successfully created with high linearity and practical accuracy. In addition, blood serum uric acid and plasma cholesterol esters contributed to the stratification of cases.
Conclusions: These findings reveal the blood metabolic signatures of hikikomori, which are key to elucidating the pathophysiology of hikikomori and also useful as an index for monitoring the treatment course for rehabilitation.
{"title":"Blood metabolic signatures of hikikomori, pathological social withdrawal.","authors":"Daiki Setoyama, Toshio Matsushima, Kohei Hayakawa, Tomohiro Nakao, Shigenobu Kanba, Dongchon Kang, Takahiro A Kato","doi":"10.1080/19585969.2022.2046978","DOIUrl":"https://doi.org/10.1080/19585969.2022.2046978","url":null,"abstract":"<p><strong>Background: </strong>A severe form of pathological social withdrawal, 'hikikomori,' has been acknowledged in Japan, spreading worldwide, and becoming a global health issue. The pathophysiology of hikikomori has not been clarified, and its biological traits remain unexplored.</p><p><strong>Methods: </strong>Drug-free patients with hikikomori (<i>n</i> = 42) and healthy controls (<i>n</i> = 41) were recruited. Psychological assessments for the severity of hikikomori and depression were conducted. Blood biochemical tests and plasma metabolome analysis were performed. Based on the integrated information, machine-learning models were created to discriminate cases of hikikomori from healthy controls, predict hikikomori severity, stratify the cases, and identify metabolic signatures that contribute to each model.</p><p><strong>Results: </strong>Long-chain acylcarnitine levels were remarkably higher in patients with hikikomori; bilirubin, arginine, ornithine, and serum arginase were significantly different in male patients with hikikomori. The discriminative random forest model was highly performant, exhibiting an area under the ROC curve of 0.854 (confidential interval = 0.648-1.000). To predict hikikomori severity, a partial least squares PLS-regression model was successfully created with high linearity and practical accuracy. In addition, blood serum uric acid and plasma cholesterol esters contributed to the stratification of cases.</p><p><strong>Conclusions: </strong>These findings reveal the blood metabolic signatures of hikikomori, which are key to elucidating the pathophysiology of hikikomori and also useful as an index for monitoring the treatment course for rehabilitation.</p>","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"23 1","pages":"14-28"},"PeriodicalIF":8.3,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01eCollection Date: 2021-01-01DOI: 10.1080/19585969.2022.2043128
Raffaele Falsaperla, Giovanna Vitaliti, Simona Domenica Marino, Andrea Domenico Praticò, Janette Mailo, Michela Spatuzza, Maria Roberta Cilio, Rosario Foti, Martino Ruggieri
Graph theoretical studies have been designed to investigate network topologies during life. Network science and graph theory methods may contribute to a better understanding of brain function, both normal and abnormal, throughout developmental stages. The degree to which childhood epilepsies exert a significant effect on brain network organisation and cognition remains unclear. The hypothesis suggests that the formation of abnormal networks associated with epileptogenesis early in life causes a disruption in normal brain network development and cognition, reflecting abnormalities in later life. Neurological diseases with onset during critical stages of brain maturation, including childhood epilepsy, may threaten this orderly neurodevelopmental process. According to the hypothesis that the formation of abnormal networks associated with epileptogenesis in early life causes a disruption in normal brain network development, it is then mandatory to perform a proper examination of children with new-onset epilepsy early in the disease course and a deep study of their brain network organisation over time. In regards, graph theoretical analysis could add more information. In order to facilitate further development of graph theory in childhood, we performed a systematic review to describe its application in functional dynamic connectivity using electroencephalographic (EEG) analysis, focussing on paediatric epilepsy.
{"title":"Graph theory in paediatric epilepsy: A systematic review.","authors":"Raffaele Falsaperla, Giovanna Vitaliti, Simona Domenica Marino, Andrea Domenico Praticò, Janette Mailo, Michela Spatuzza, Maria Roberta Cilio, Rosario Foti, Martino Ruggieri","doi":"10.1080/19585969.2022.2043128","DOIUrl":"https://doi.org/10.1080/19585969.2022.2043128","url":null,"abstract":"<p><p>Graph theoretical studies have been designed to investigate network topologies during life. Network science and graph theory methods may contribute to a better understanding of brain function, both normal and abnormal, throughout developmental stages. The degree to which childhood epilepsies exert a significant effect on brain network organisation and cognition remains unclear. The hypothesis suggests that the formation of abnormal networks associated with epileptogenesis early in life causes a disruption in normal brain network development and cognition, reflecting abnormalities in later life. Neurological diseases with onset during critical stages of brain maturation, including childhood epilepsy, may threaten this orderly neurodevelopmental process. According to the hypothesis that the formation of abnormal networks associated with epileptogenesis in early life causes a disruption in normal brain network development, it is then mandatory to perform a proper examination of children with new-onset epilepsy early in the disease course and a deep study of their brain network organisation over time. In regards, graph theoretical analysis could add more information. In order to facilitate further development of graph theory in childhood, we performed a systematic review to describe its application in functional dynamic connectivity using electroencephalographic (EEG) analysis, focussing on paediatric epilepsy.</p>","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"23 1","pages":"3-13"},"PeriodicalIF":8.3,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01eCollection Date: 2021-01-01DOI: 10.1080/19585969.2022.2042164
Kamyar Keramatian, Ivan J Torres, Lakshmi N Yatham
Introduction: This narrative review of systematic reviews and meta-analyses aims at compiling available evidence in various aspects of neurocognitive functioning in Bipolar Disorder (BD). Methods: We conducted a MEDLINE literature search and identified 38 relevant systematic reviews and metaanalyses. Results: Current evidence suggests that BD is associated with cognitive impairment across multiple domains and during all clinical states. However, there is a considerable cognitive heterogeneity within BD, which cannot be explained by clinical subtypes, and the pattern of neurocognitive impairment in BD overlaps with other psychiatric conditions such as major depression and schizophrenia. Residual depressive symptoms, poor clinical course and higher number of manic episodes may negatively impact cognitive performance, which is a major predictor of general functioning in BD. Evidence from available prospective studies does not support the notion of progressive cognitive decline in BD while some evidence exists to suggest patients may show some improvements in cognitive functioning following the first manic episode. Furthermore, a subset of patients may show premorbid cognitive abnormalities that could signal an early neurodevelopmental aetiology. Preliminary findings from small studies identify potential pro-cognitive effects of Cognitive Remediation, erythropoietin, intranasal insulin, lurasidone, mifepristone, repetitive Transcranial Magnetic Stimulation and transcranial Direct Current Stimulation in BD. Discussion: Longitudinal studies in high-risk individuals can provide a better understanding of the development and progression of neurocognitive impairment in BD. Largescale randomised control trials are needed to compare the pro-cognitive efficacy of various pharmacological and non-pharmacological interventions in different cognitive subgroups of patients at different stages of BD.
{"title":"Neurocognitive functioning in bipolar disorder: What we know and what we don't.","authors":"Kamyar Keramatian, Ivan J Torres, Lakshmi N Yatham","doi":"10.1080/19585969.2022.2042164","DOIUrl":"https://doi.org/10.1080/19585969.2022.2042164","url":null,"abstract":"<p><p><b>Introduction:</b> This narrative review of systematic reviews and meta-analyses aims at compiling available evidence in various aspects of neurocognitive functioning in Bipolar Disorder (BD). <b>Methods:</b> We conducted a MEDLINE literature search and identified 38 relevant systematic reviews and metaanalyses. <b>Results:</b> Current evidence suggests that BD is associated with cognitive impairment across multiple domains and during all clinical states. However, there is a considerable cognitive heterogeneity within BD, which cannot be explained by clinical subtypes, and the pattern of neurocognitive impairment in BD overlaps with other psychiatric conditions such as major depression and schizophrenia. Residual depressive symptoms, poor clinical course and higher number of manic episodes may negatively impact cognitive performance, which is a major predictor of general functioning in BD. Evidence from available prospective studies does not support the notion of progressive cognitive decline in BD while some evidence exists to suggest patients may show some improvements in cognitive functioning following the first manic episode. Furthermore, a subset of patients may show premorbid cognitive abnormalities that could signal an early neurodevelopmental aetiology. Preliminary findings from small studies identify potential pro-cognitive effects of Cognitive Remediation, erythropoietin, intranasal insulin, lurasidone, mifepristone, repetitive Transcranial Magnetic Stimulation and transcranial Direct Current Stimulation in BD. <b>Discussion:</b> Longitudinal studies in high-risk individuals can provide a better understanding of the development and progression of neurocognitive impairment in BD. Largescale randomised control trials are needed to compare the pro-cognitive efficacy of various pharmacological and non-pharmacological interventions in different cognitive subgroups of patients at different stages of BD.</p>","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"23 1","pages":"29-38"},"PeriodicalIF":8.3,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1080/19585969.2022.2128697
Sabrina Mörkl, Andreas Oberascher, Josef M Tatschl, Sonja Lackner, Thomaz F S Bastiaanssen, Mary I Butler, Maximilian Moser, Matthias Frühwirth, Harald Mangge, John F Cryan, Timothy G Dinan, Sandra J Holasek
Introduction: A functional reciprocity between the gut microbiome and vagal nerve activity has been suggested, however, human studies addressing this phenomenon are limited.
Methods: Twenty-four-hour cardiac vagal activity (CVA) was assessed from 73 female participants (aged 24.5 ± 4.3 years). Additionally, stool samples were subjected to 16SrRNA gene analysis (V1-V2). Quantitative Insights Into Microbial Ecology (QIIME) was used to analyse microbiome data. Additionally, inflammatory parameters (such as CRP and IL-6) were derived from serum samples.
Results: Daytime CVA correlated significantly with gut microbiota diversity (rsp = 0.254, p = 0.030), CRP (rsp = -0.348, p = 0.003), and IL-6 (rsp = -0.320, p = 0.006). When the group was divided at the median of 24 h CVA (Mdn = 1.322), the following features were more abundant in the high CVA group: Clostridia (Linear discriminant analysis effect size (LDA) = 4.195, p = 0.029), Clostridiales (LDA = 4.195, p = 0.029), Lachnospira (LDA = 3.489, p = 0.004), Ruminococcaceae (LDA = 4.073, p = 0.010), Faecalibacterium (LDA = 3.982, p = 0.042), Lactobacillales (LDA = 3.317, p = 0.029), Bacilli (LDA = 3.294, p = 0.0350), Streptococcaceae (LDA = 3.353, p = 0.006), Streptococcus (LDA = 3.332, p = 0.011). Based on Dirichlet multinomial mixtures two enterotypes could be detected, which differed significantly in CVA, age, BMI, CRP, IL-6, and diversity.
Conclusions: As an indicator of gut-brain communication, gut microbiome analysis could be extended by measurements of CVA to enhance our understanding of signalling via microbiota-gut-brain-axis and its alterations through psychobiotics.
导读:肠道微生物群和迷走神经活动之间的功能互惠已被提出,然而,针对这一现象的人类研究是有限的。方法:对73名女性(年龄24.5±4.3岁)进行24小时心脏迷走神经活动(CVA)评估。此外,粪便样本进行16SrRNA基因分析(V1-V2)。微生物生态学定量洞察(QIIME)用于分析微生物组数据。此外,从血清样本中提取炎症参数(如CRP和IL-6)。结果:白天CVA与肠道菌群多样性(r sp = 0.254, p = 0.030)、CRP (r sp = -0.348, p = 0.003)、IL-6 (r sp = -0.320, p = 0.006)显著相关。在24 h CVA中位数(Mdn = 1.322)分组时,高CVA组的以下特征更为丰富:梭菌(线性判别分析效应值(LDA) = 4.195, p = 0.029)、梭菌(LDA = 4.195, p = 0.029)、毛螺旋体(LDA = 3.489, p = 0.004)、瘤胃球菌科(LDA = 4.073, p = 0.010)、粪杆菌(LDA = 3.982, p = 0.042)、乳酸杆菌(LDA = 3.317, p = 0.029)、杆菌(LDA = 3.294, p = 0.0350)、链球菌科(LDA = 3.353, p = 0.006)、链球菌(LDA = 3.332, p = 0.011)。基于Dirichlet多项式混合可以检测到两种肠型,CVA、年龄、BMI、CRP、IL-6和多样性差异显著。结论:作为肠-脑通讯的一个指标,肠道微生物组分析可以通过CVA的测量来扩展,以增强我们对微生物-肠-脑-轴信号传导及其通过心理生物改变的理解。
{"title":"Cardiac vagal activity is associated with gut-microbiome patterns in women-An exploratory pilot study.","authors":"Sabrina Mörkl, Andreas Oberascher, Josef M Tatschl, Sonja Lackner, Thomaz F S Bastiaanssen, Mary I Butler, Maximilian Moser, Matthias Frühwirth, Harald Mangge, John F Cryan, Timothy G Dinan, Sandra J Holasek","doi":"10.1080/19585969.2022.2128697","DOIUrl":"https://doi.org/10.1080/19585969.2022.2128697","url":null,"abstract":"<p><strong>Introduction: </strong>A functional reciprocity between the gut microbiome and vagal nerve activity has been suggested, however, human studies addressing this phenomenon are limited.</p><p><strong>Methods: </strong>Twenty-four-hour cardiac vagal activity (CVA) was assessed from 73 female participants (aged 24.5 ± 4.3 years). Additionally, stool samples were subjected to 16SrRNA gene analysis (V1-V2). Quantitative Insights Into Microbial Ecology (QIIME) was used to analyse microbiome data. Additionally, inflammatory parameters (such as CRP and IL-6) were derived from serum samples.</p><p><strong>Results: </strong>Daytime CVA correlated significantly with gut microbiota diversity (<i>r</i> <sub>sp</sub> = 0.254, <i>p</i> = 0.030), CRP (<i>r</i> <sub>sp</sub> = -0.348, <i>p</i> = 0.003), and IL-6 (<i>r</i> <sub>sp</sub> = -0.320, <i>p</i> = 0.006). When the group was divided at the median of 24 h CVA (Mdn = 1.322), the following features were more abundant in the high CVA group: <i>Clostridia</i> (Linear discriminant analysis effect size (LDA) = 4.195, <i>p</i> = 0.029), <i>Clostridiales</i> (LDA = 4.195, <i>p</i> = 0.029), <i>Lachnospira</i> (LDA = 3.489, <i>p</i> = 0.004), <i>Ruminococcaceae</i> (LDA = 4.073, <i>p</i> = 0.010), <i>Faecalibacterium</i> (LDA = 3.982, <i>p</i> = 0.042), <i>Lactobacillales</i> (LDA = 3.317, <i>p</i> = 0.029), <i>Bacilli</i> (LDA = 3.294, <i>p</i> = 0.0350), <i>Streptococcaceae</i> (LDA = 3.353, <i>p</i> = 0.006), <i>Streptococcus</i> (LDA = 3.332, <i>p</i> = 0.011). Based on Dirichlet multinomial mixtures two enterotypes could be detected, which differed significantly in CVA, age, BMI, CRP, IL-6, and diversity.</p><p><strong>Conclusions: </strong>As an indicator of gut-brain communication, gut microbiome analysis could be extended by measurements of CVA to enhance our understanding of signalling <i>via</i> microbiota-gut-brain-axis and its alterations through psychobiotics.</p>","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"24 1","pages":"1-9"},"PeriodicalIF":8.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10367778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.7551/mitpress/13633.003.0013
{"title":"Lost Illusions, or From Intellectronics to Informatics","authors":"","doi":"10.7551/mitpress/13633.003.0013","DOIUrl":"https://doi.org/10.7551/mitpress/13633.003.0013","url":null,"abstract":"","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"14 1","pages":""},"PeriodicalIF":8.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73650511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.7551/mitpress/13633.003.0016
{"title":"The Ethics of Technology and the Technology of Ethics","authors":"","doi":"10.7551/mitpress/13633.003.0016","DOIUrl":"https://doi.org/10.7551/mitpress/13633.003.0016","url":null,"abstract":"","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":"2 1","pages":""},"PeriodicalIF":8.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72938712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}